Page 4 - Jeffrey Guy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

It is not based in the united states, but in the u.k. >> wow! this is pretty spectacular. >> dr. jeffrey guy is the founder and chairman of the makers of this drug. this is where they turn the plant into a medicine. >> we are able to see what each individual does. we can breed into the plant that materials that will provide us with a range of beneficial effects. >> the price tag, $32,500 a year. so far johnna has befoen receivg the medication through a trial. >> i think everything with a child with significant medical needs is always hoping for a miracle. but in lieu of that, i think we just w...

Improvements, others had no improvement at all, and there is the pesky fact that cannabis is still considered an illegal substance by the united states government. >> it's my view that the use of marijuana is detrimental. >> reporter: in fact, the company making the drug is not based in the united states but in the uk. >> wow. this is pretty spectacular. >> reporter: dr. jeffrey guy is the founder and chairman of gw pharmaceuticals, the maker of the drug. i visited the labs outside of london. this is where they turn the plant into a medicine. >> we're able to say what each individual cannabino...

>> it can protect against further brain damage. >> dr. mark rohrback developed the patent for hhs. >> how do you patent something that comes from a plant? >> we're not patenting the compound. people are free to use the compound in other ways subject to laws and other patents, so this is a method of using the compound for developing drugs to treat these types of diseases. >> like the progressive degenerative disease called chronic traumatic encephalopathy, or cte. it's caused by concussions or consistent blows to the head. >> hopefully we can intervene in the late stage of -- >> dean petkanis i...

Overall inflammation in the brain possibly providing benefit to many brain diseases. we first heard rumblings about this in 2013, when we visited gw pharmaceuticals in the united kingdom. >> these flowering parts and the leaves around the flowering pots are coated with thousands of little balls. they're called tricons and the content is about 67% pure cannabinoid. >> gw's chairman dr. jeffrey guy and many others believe these precious chemicals are in fact neuroprotectants. >> not damaging, but protecting the brain? >> when brain cells are stressed by trauma or other injury. >> if you're skept...

Many brain diseases. we first heard rumblings of this in 2013 when we visited gw pharmaceuticals in the united kingdom. >> these are coated with thousands of balls. the content is about 67 about pure cabinoid. >> gw's chairman dr. jeffrey guy and many others believe these precious chemicals are in fact neuroprotectants. >> not damaging, but protecting the brain? >> when brain cells are stressed by trauma or other injury. >> if you're skeptical, consider this. the u.s. department of health and human services has an actual financial stake in this exact sort of research. their patent number 66305...